| |
| |
|
| Insider
Information: |
Shih Alvin |
| Relationship: |
EVP of Research & Deve... |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
158,334 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,003,838 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
158,334 |
|
|
| Total
Value |
$1,003,838 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Travere Therapeutics, Inc |
TVTX |
EVP of Research & Deve... |
2016-09-01 |
158,334 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
7 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TVTX |
Travere Therapeutics, Inc |
EVP of Research & Development |
• – – |
2016-09-01 |
4 |
AS |
$16.24 |
$142,059 |
D/D |
(8,750) |
158,334 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
EVP of Research & Development |
• – – |
2016-06-01 |
4 |
AS |
$17.75 |
$155,284 |
D/D |
(8,750) |
167,084 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
EVP of Research & Development |
• – – |
2016-03-01 |
4 |
AS |
$14.35 |
$125,569 |
D/D |
(8,750) |
175,834 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
EVP of Research & Development |
• – – |
2015-12-09 |
4 |
AS |
$20.83 |
$182,262 |
D/D |
(8,750) |
184,584 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
EVP of Research & Development |
• – – |
2015-10-06 |
4 |
AS |
$19.58 |
$176,073 |
D/D |
(8,750) |
193,334 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
EVP of Research & Development |
• – – |
2015-06-26 |
4 |
AS |
$32.70 |
$912,850 |
D/D |
(27,916) |
202,084 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
EVP of Research & DevelopmentO |
• – – |
2014-05-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
230,000 |
|
- |
|
7 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
